Influence of increased age on the development of herpes stromal keratitis.

Exp Gerontol

Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Published: October 2003

Herpes stromal keratitis (HSK) is the leading infectious cause of blindness in the United States and is a consequence of events following HSV-1 infection of the eye. The pathology of the disease is currently thought to be caused by a destructive, CD4(+) T helper 1 (Th1) type inflammatory immune response within the cornea rather than a cytopathic response elicited by the virus. A large percentage of people can become infected with HSV-1 as children whereas some studies have concluded that many others do not become infected with HSV-1 until much later in life. In this paper we investigate the role of increasing age on ocular HSV-1 infection. Following an ocular infection of mice with HSV-1 we observed greater pathology in the cornea during both early and late time-points in adult mice when compared to young animals. No significant differences in viral titers were observed in either the eyes or trigeminal ganglia from infected mice, regardless of age, suggesting that increased viral load may not be responsible for the ocular pathology in the adult mice. We hypothesize that age-related changes in the immune response may predispose adult animals to HSK disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0531-5565(03)00187-6DOI Listing

Publication Analysis

Top Keywords

herpes stromal
8
stromal keratitis
8
hsv-1 infection
8
immune response
8
infected hsv-1
8
adult mice
8
hsv-1
5
influence increased
4
increased age
4
age development
4

Similar Publications

Article Synopsis
  • Herpes Zoster Ophthalmicus (HZO) is increasingly affecting younger individuals, particularly those under 40 years old, which raises questions about its rising incidence in this demographic.
  • A review of 56 relevant patient records showed that conjunctivitis is the most common symptom, while other eye conditions like keratitis and uveitis are also prevalent among HZO patients.
  • Factors such as immune status, diet, environment, and vaccination history are contributing to the increasing trend of HZO in younger populations, highlighting the need for improved patient care and public health strategies.
View Article and Find Full Text PDF

The recurrent herpes simplex virus-1 (HSV-1) infection of the cornea can cause the development of herpes stromal keratitis (HSK). This chronic immunoinflammatory condition is a major cause of infection-induced vision loss. The previous episodes of HSK increase the risk of future recurrences in the same cornea.

View Article and Find Full Text PDF

Trigeminal Trophic Syndrome With Herpetic Keratitis.

Cornea

October 2024

John F. Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO.

Article Synopsis
  • This study reports a unique case of trigeminal trophic syndrome occurring alongside herpetic keratitis in a 42-year-old male with a history of severe facial injuries and nerve damage.
  • The patient was found to have significant facial sensitivity loss and corneal issues linked to herpes, leading to a diagnosis of herpetic keratitis and ulceration due to trigeminal trophic syndrome.
  • Treatment involved antibiotics, antiviral medication, and topical steroids, resulting in improved vision and the use of a custom facial mask to prevent self-harm.
View Article and Find Full Text PDF

Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy.

Ocul Surf

October 2024

Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China; School of Ophthalmology, Shandong First Medical University, Qingdao, China; State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Qingdao, China. Electronic address:

Purpose: Neurotrophic keratopathy (NK) is a degenerative corneal condition resulting from corneal nerve injury. Current therapies, including the recombinant human nerve growth factor (rhNGF) therapy, requires continuous administration. This study aims to develop a novel and highly effective gene therapy strategy for the prevention and treatment of NK.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!